€0.00 (0 items)
Recherche sur le site
Liste des catégories

Générique Doxepin - Sinequan

Recherche par lettre:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Sinequan

Générique Sinequan

Doxepin 10/25/75mg

Sinequan Générique fait partie d'un groupe de médicaments appelés les antidépresseurs tricycliques. Il est utilisé pour traiter la dépression et l'anxiété.

Plus d'information »
€0.44 Achetez!
Choose Your language:
Bookmarks sociaux
Testimonials
J'ai reçu la commande à temps et ce medicament fonctionne parfaitement. Ma femme vous dit merci aussi, notre lit, couvertures etc... Mark
En savoir plus »

Notre page de facturation est certifiée par:

Secure shopping certificates


Special Offer!

Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South Korea - MarketWatch (press release)
Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South KoreaMarketWatch (press release)Silenor is a low-dose (3 mg and 6 mg) oral tablet formulation of doxepin, and is the first and only non-scheduled prescription sleep medication approved to treat insomnia characterized by difficulties with sleep maintenance
Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea - SunHerald.com
SunHerald
Infinite Itch: Learning to Live With Hives - New York Times (blog)
New York Times (blog)Infinite Itch: Learning to Live With HivesNew York Times (blog)But doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training
Infinite itch: Learning to live with hives - Sarasota Herald-Tribune
Sarasota Herald-TribuneInfinite itch: Learning to live with hivesSarasota Herald-TribuneBut doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training
Somaxon, CJ CheilJedang sign Silenor commercialization agreement - Pharmaceutical Business Review
Somaxon, CJ CheilJedang sign Silenor commercialization agreementPharmaceutical Business ReviewSomaxon Pharmaceuticals and CJ CheilJedang have signed a commercialization agreement in South Korea for Silenor (doxepin) to treat insomnia
Centralux Ltd
bookmark Ajouter aux favoris
subscribe S'abonner à la newsletter